Treated as a serious health protocol
Health warning issued for women using GLP-1 weight loss medications CINCINNATI (WKRC) - Health experts are cautioning women who are using GLP-1 weight loss medications about potential complications related to changes in body balance
How do you leverage both your own and third-party analytics to optimize decisions
Figure 3: The figure shows the gender distribution of GLP-1 agonist users by age group in 2023, comparing adolescents (12-17 years) with young adults (18-25 years)
We used the search terms fracture, osteoporosis, semaglutide, calorie restriction, bariatric surgery, bone density, bone turnover markers, liraglutide, tirzepatide, Glucagon-like peptide 1, and glucagon-like peptide receptor analogues in combination with the terms obesity and diabetes